William W. Douglas

3.4k total citations
43 papers, 2.4k citations indexed

About

William W. Douglas is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, William W. Douglas has authored 43 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 16 papers in Molecular Biology and 12 papers in Physiology. Recurrent topics in William W. Douglas's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Medical Imaging and Pathology Studies (7 papers) and Sarcoidosis and Beryllium Toxicity Research (6 papers). William W. Douglas is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (16 papers), Medical Imaging and Pathology Studies (7 papers) and Sarcoidosis and Beryllium Toxicity Research (6 papers). William W. Douglas collaborates with scholars based in United States. William W. Douglas's co-authors include Jay H. Ryu, Theoharis C. Theoharides, Darrell R. Schroeder, Henry D. Tazelaar, Paul A. Decker, Thomas E. Hartman, Werner Sieghart, Paul Greengard, Robert P. Hartman and Jeffrey L. Myers and has published in prestigious journals such as Nature, Science and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

William W. Douglas

42 papers receiving 2.3k citations

Peers

William W. Douglas
Paul F. Mercer United Kingdom
Takahiro Suzuki Japan
Sylvie Lantuéjoul France
Joseph O’Connell United States
Pascale Marcorelles France
David Ramos‐Barbón Spain
Omar Tliba United States
Jane A. Warner United Kingdom
Francis White United States
P. Vaith Germany
Paul F. Mercer United Kingdom
William W. Douglas
Citations per year, relative to William W. Douglas William W. Douglas (= 1×) peers Paul F. Mercer

Countries citing papers authored by William W. Douglas

Since Specialization
Citations

This map shows the geographic impact of William W. Douglas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William W. Douglas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William W. Douglas more than expected).

Fields of papers citing papers by William W. Douglas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William W. Douglas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William W. Douglas. The network helps show where William W. Douglas may publish in the future.

Co-authorship network of co-authors of William W. Douglas

This figure shows the co-authorship network connecting the top 25 collaborators of William W. Douglas. A scholar is included among the top collaborators of William W. Douglas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William W. Douglas. William W. Douglas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ryu, Jay H., Jeffrey L. Myers, Stephen A. Capizzi, et al.. (2005). Desquamative Interstitial Pneumonia and Respiratory Bronchiolitis-Associated Interstitial Lung Disease. CHEST Journal. 127(1). 178–184. 126 indexed citations
2.
Collard, Harold R., Jay H. Ryu, William W. Douglas, et al.. (2004). Combined Corticosteroid and Cyclophosphamide Therapy Does Not Alter Survival in Idiopathic Pulmonary Fibrosis. CHEST Journal. 125(6). 2169–2174. 103 indexed citations
3.
Vassallo, Robert, Eric A. Jensen, Thomas V. Colby, et al.. (2003). The Overlap Between Respiratory Bronchiolitis and Desquamative Interstitial Pneumonia in Pulmonary Langerhans Cell Histiocytosis. CHEST Journal. 124(4). 1199–1205. 89 indexed citations
4.
Douglas, William W., Henry D. Tazelaar, Thomas E. Hartman, et al.. (2001). Polymyositis–Dermatomyositis-associated Interstitial Lung Disease. American Journal of Respiratory and Critical Care Medicine. 164(7). 1182–1185. 390 indexed citations
5.
Douglas, William W., Jay H. Ryu, & Darrell R. Schroeder. (2001). Idiopathic Pulmonary Fibrosis. CHEST Journal. 120(1). S62–S62. 1 indexed citations
6.
Douglas, William W., Jay H. Ryu, & Darrell R. Schroeder. (2000). Idiopathic Pulmonary Fibrosis: Impact of Oxygen and Colchicine, Prednisone, or No Therapy on Survival. American Journal of Respiratory and Critical Care Medicine. 161(4). 1172–1178. 185 indexed citations
7.
Prakash, Udaya B. S., et al.. (1999). Radiation-Induced Pneumonitis in the “Nonirradiated” Lung. Mayo Clinic Proceedings. 74(1). 27–36. 69 indexed citations
8.
Douglas, William W., Jay H. Ryu, Stephen J. Swensen, et al.. (1998). Colchicine versus Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis: A Randomized Prospective Study. American Journal of Respiratory and Critical Care Medicine. 158(1). 220–225. 131 indexed citations
9.
Douglas, William W., Jay H. Ryu, Darrell R. Schroeder, et al.. (1997). Colchicine Versus Prednisone as Treatment of Usual Interstitial Pneumonia. Mayo Clinic Proceedings. 72(3). 201–209. 47 indexed citations
10.
Shibuya, Izumi, Sathapana Kongsamut, & William W. Douglas. (1997). Both GABAA and GABAB receptors participate in suppression of [Ca2+]i pulsing in toad melanotrophs. European Journal of Pharmacology. 321(2). 241–246. 9 indexed citations
11.
Olopade, Christopher O., Thomas B. Crotty, William W. Douglas, Thomas V. Colby, & Sanjiv Sur. (1995). Chronic Eosinophilic Pneumonia and Idiopathic Bronchiolitis Obliterans Organizing Pneumonia: Comparison of Eosinophil Number and Degranulation by Immunofluorescence Staining for Eosinophil-Derived Major Basic Protein. Mayo Clinic Proceedings. 70(2). 137–142. 21 indexed citations
12.
Douglas, William W. & Izumi Shibuya. (1993). Calcium Signals in Melanotrophs and Their Relation to Autonomous Secretion and Its Modification by Inhibitory and Stimulatory Ligands. Annals of the New York Academy of Sciences. 680(1). 229–245. 13 indexed citations
13.
Peters, Steve G., John C. McDougall, William W. Douglas, Douglas T. Coles, & Richard A. DeRemee. (1993). Colchicine in the Treatment of Pulmonary Fibrosis. CHEST Journal. 103(1). 101–104. 53 indexed citations
14.
Shibuya, Izumi & William W. Douglas. (1993). Measurements of Cytosolic Free Calcium in Melanotrophs of Xenopus laevis. Annals of the New York Academy of Sciences. 680(1). 606–608. 12 indexed citations
15.
Kongsamut, Sathapana, Izumi Shibuya, & William W. Douglas. (1991). Why Are Several Inhibitory Transmitters Present in the Innervation of Pituitary Melanotrophs?. Neuroendocrinology. 54(6). 599–606. 15 indexed citations
16.
Douglas, William W., et al.. (1986). Effects of BAY K 8644 and Other Dihydropyridines on Basal and Potassium-Evoked Output of MSH from Mouse Melanotrophs in vitro. Neuroendocrinology. 44(3). 384–389. 22 indexed citations
17.
Skillrud, David M. & William W. Douglas. (1985). Survival in Adult Respiratory Distress Syndrome Caused by Blastomycosis Infection. Mayo Clinic Proceedings. 60(4). 266–269. 15 indexed citations
18.
Nemeth, Edward F. & William W. Douglas. (1982). Lipoxygenase inhibitors exert secretagogue-specific effects on mast cell exocytosis. European Journal of Pharmacology. 79(3-4). 315–318. 4 indexed citations
19.
Theoharides, Theoharis C. & William W. Douglas. (1981). Mast cell histamine secretion in response to somatostatin analogues: Structural considerations. European Journal of Pharmacology. 73(2-3). 131–136. 55 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul F. Mercer Breakdown of academic impact, for papers by Takahiro Suzuki Breakdown of academic impact, for papers by Sylvie Lantuéjoul Breakdown of academic impact, for papers by Joseph O’Connell Breakdown of academic impact, for papers by Pascale Marcorelles Breakdown of academic impact, for papers by David Ramos‐Barbón Breakdown of academic impact, for papers by Omar Tliba Breakdown of academic impact, for papers by Jane A. Warner Breakdown of academic impact, for papers by Francis White Breakdown of academic impact, for papers by P. Vaith
Rankless by CCL
2026